Life Extension Magazine August 2004
Case Report: Migraine Solution
By Dr. Sergey A. Dzugan
|LE Magazine August 2004|
|Case Report: Migraine Solution |
By Dr. Sergey A. Dzugan
Sergey A. Dzugan, MD, PhD, was formerly chief of cardiovascular surgery at the Donetsk Regional Medical Center in Donetsk, Ukraine. Dr. Dzugan’s current primary interests are anti-aging, biological therapy for cancer, cholesterol, and hormonal disorders.
Migraine, often described as an intense pulsing or throbbing pain in one area of the head, can be a debilitating, even life-threatening disorder. The crippling effects of migraine have been known for thousands of years. In fact, the Ebers papyrus of ancient Egypt, the world’s oldest preserved medical document, contains a long chapter on purported remedies for migraine.1
The specific causes of migraine remain unknown.2 Despite ad-vances in the understanding of the pathophysiology of migraine, effective new treatment options, and repeated initiatives over the years, migraine remains an under-recognized, under-diagnosed, and under-treated health condition in everyday clinical practice. Most patients attempt, without success, to treat their headaches with over-the-counter medications.3,4
In a previously published paper, we described migraine as a consequence of a loss of neurohormonal and metabolic integrity.5 In this case history, we present a patient with long-lasting, severe migraine and a new and very promising approach to correcting this pathology.
Typically, patient experienced two or three migraine attacks each week. Usually the migraine started in the early afternoon. He often had to go home from work and try to sleep, blocking out all light and sound, and using cold compresses. He rarely suffered an attack at night.
For a number of years, CH had simply taken aspirin, Tylenol®, and usually something with caffeine to try to relieve his headaches, without much success. He eventually began to use Imitrex® by injection, a prescription medicine for acute migraine. Although Imitrex® is also available in the form of pills and nasal spray, he had found the pills were not as effective or quick acting, while the nasal spray would drip down his throat and cause him to become nauseous. Usually after taking the injection and lying down for 15 minutes, he could completely abort the migraine. He had also tried pill forms of other medications such as Zomig®, Amerge®, and Maxalt®, but none worked as well as Imitrex®. Occasionally, if CH did not take a shot early enough in the day, he would then have to take an additional one or two doses of Imitrex®.
Patient had experienced visual disturbances in about 20% of his migraine attacks and nausea in about 10% of them since he began taking Imitrex® in 1995. He became very adept at recognizing migraine before actually experiencing any head pain, and has not suffered many “full-blown” migraine attacks in recent years. He has always been concerned about the amount of Imitrex® he takes weekly, which is usually two or three doses, but sometimes six or seven.
Several years ago, CH also started taking Midrin®, another prescription medication, if he started to get migraine fairly early in the day (three capsules, usually with a Coke for the caffeine). In most instances, however, he was merely postponing the eventual Imitrex® injection. For years now, patient has kept Imitrex® with him at all times (in his desk, briefcase, car, and, depending on where he was or what he was doing, in his pocket). He credits Imitrex® with enabling him to maintain steady employment, become successful in his career, and otherwise live a normal life.
CH had a vasectomy in his mid-twenties, but he does not recall a change in the frequency of his migraine following surgery. Five years ago, his doctor in-formed him that his total cholesterol was high. Because of his concerns about the dangers of consuming animal products, patient has followed a vegetarian diet for years.
Both his mother and father have suffered from headaches their entire lives. His mother experiences fairly typical migraine, but only a few times a year. His father has almost daily headaches that do not appear to be migraine, and “lives on Excedrin®.”
About three and a half years ago, CH had a lower back problem. Magnetic resonance imaging showed that all of the discs in his back seemed to be “thinner” than they should be. Imitrex® was suspected to be the cause of this cartilage deterioration (the Physicians’ Desk Reference entry on Imitrex® alludes to this potential side effect). Patient was terrified by the possibility that he had permanently damaged his health and would suffer for years as a result. His neurologist did not confirm a connection between his use of Imitrex® and the back problem. It was recommended that he continue using Imitrex® because it seemed to work for him. Later, CH had surgery to fix his herniated disk, and he has not had any back problems since the surgery.
Over the years, patient has asked many doctors what he could do about his migraine. He has kept countless diaries tracking possible triggers, only to decide that he had a seemingly unending list of potential suspects: stress, computer usage, too little sleep, too much sleep, changes in food or caffeine intake, bright lights, bad smells, wine, cheese, chocolate, and so on. He could not find a common denominator, and was always told to just continue taking Imitrex® since it worked so well for him. During this period, he also began taking an antidepressant (20 mg of Paxil® daily) for symptoms common to depression, including fatigue, lack of motivation, poor memory, and inability to concentrate. Early on, patient “thought” he had noticed a decrease in the frequency of migraine while on Paxil®, and as a result he has taken it religiously for years.
CH has tried practically all the currently available supplements for migraine, including feverfew, butterbur extract (Petadolex®), and magnesium. He has likewise used a prescription drug for epilepsy to try to reduce the frequency of migraine, but without success. During these experiments, he continued to use Imitrex®, often fighting with insurance companies to be reimbursed for the injectable form of the drug and the quantity of it required. Patient eventually discovered that he could “half dose” in many cases and still abort his migraine. He conservatively estimates that he has taken over 800 doses of Imitrex® and thousands of Midrin® capsules, and shudders to think of the total costs of these drugs in prescription co-pays and insurance outlays. Based on the $50 cost of an injectable dose, he estimates that he has probably spent at least approximately $40,000 on Imitrex® alone.